Upload
mn-savita
View
2.337
Download
1
Embed Size (px)
Citation preview
NURSING PROCESS FOR MOTHER:
1. NURSING DIAGNOSIS : Risk of eclampsia related to pre-eclampsia as evidenced by Hypertension
B.P.=160/100 And protein urea +2
SUBJECTIVE DATA OBJECTIVE DATA Patient is saying she is felling weakness Blood pressure of the patient is 160/100 and
protein urea +2
DESIRED GOAL/ OUTCOME To reduce blood pressure to normal i.e., 120/80
AND reduce protein urea and thereby reducing risk of eclampsia.
PLANNING IMPLEMENTATION RATIONALE
Advised mother to take adequate rest.
Monitored intake output of the patient daily
Administered anti-hypertensive medicine as doctor’s prescription
Monitored blood pressure regularly
Monitored blood pressure regularly;
Administered magnesium sulphate as doctor’s prescription.
Advised mother to take adequate rest.
Monitored intake output of the patient daily
Advised low fat and low salt diet i.e., not to add extra salt in the diet.
Advised her postnatal excises
Provide objective data
As a prophylaxis of eclampsia
To prevent fluid and sodium retention in the body and thereby reducing the B.P.
To maintain B.P. and reduce weight.
EVALUATION OF GOAL
Patient has reduced risk of eclampsia as evidenced by Patient reduced blood pressure ; B.P.= 130/80& Protein urea nil.
2. NURSING DIAGNOSIS : Acute pain related cesarean section as evidenced by pain intensity=4
SUBJECTIVE DATA OBJECTIVE DATA Patient complain of pain at the LSCS site Pain analog scale pain intensity= 4
DESIRED GOAL/ OUTCOME
Patient will experience no pain or reduced pain to the level of acceptance
PLANNING IMPLEMENTATION RATIONALE
Administered analgesia as advised by doctor
Help her to ambulate Advised patient to take
sitz bath
Assessed patient vitals
Assessed the level of pain
Patient was administered analgesia Tab brufen 400mg B.D. for 5 days
Patient was give comfortable position i.e., propped up position
Told her to cross the legs in lying down position
Advised her to avoid sitting in crossed leg position.
Advised patient to carry out deep breathing exercise
To get objective data
To reduce pain
To provide sense of wellness
To reduce aggravating factors
To maintain intactness of the stiches
To improve respiration and circulation
EVALUATION OF GOAL Patient pain is reduced as verbalized by the patient and pain intensity =1
3. NURSING DIAGNOSIS : Fluid volume excess related to pre-eclacmptia as evidenced by the edema
over legs and ankle and decreased urine output
SUBJECTIVE DATA OBJECTIVE DATA Patient was saying that she is having swelling on foot, ankle and legs
Patient have edema over foot, leg and ankle and decreased output and proteinuria= + 2
DESIRED GOAL/ OUTCOME
Maintenance of ideal body weight without excess fluid through nursing intervention.
PLANNING IMPLEMENTATION RATIONALE
Identify potential source of fluid excess like medications. Food and intravenous fluids
Explained patient and family the rationale of the fluid limitation
Patient was encouraged to carry out daily oral hygiene.
Urinary Catheterization was done to maintaindaily intake and output charting. I= 2500 0=1500; balance= 1000ml.
Assessed skin turgor and pressure of edema
Limit fluid intake to prescribed volume i.e., 2 liter but not restrict
Assessed respirator rate daily
To Assessed fluid status daily by maintaining record of
To assessdecrees in pressure of edemadaily
Fluid limitation is done according to urine output of the mother
EVALUATION OF GOAL Patient has reduced edema and proteinuria= nil and I=2100 ml O=1800ml
4. NURSING DIAGNOSIS : Risk of infection related to LSCS, presence of urinary catheter and I.V. cannula
SUBJECTIVE DATA OBJECTIVE DATA
Patient complains of itching at the LSCS site, redness at cannula site.
Redness & presence of urinary catheter; and cannula site; W.B.C.= 13,000 mg/dl
DESIRED GOAL/ OUTCOME
To reduce level of infection so that patient don’t have any complication
PLANNING IMPLEMENTATION RATIONALE
Taught patient about self care
Removed cannula
Removed urinary catheter
Vitals checked daily Assessed LSCS site
daily.
Vitals checked daily
Perineal care giving and catheter care given using sterile techniques
Change the dressing at incision site.
Checked the sit of the cannula Cap amclox 500mg T.D.S. given to
the patient for 5 days
To reduce level of infection
Antibiotics reduce infection.
EVALUATION OF GOAL
Patient is free from infection as evidence by reduced redness and W.B.C= 7,000mg/dl
5. NURSING DIAGNOSIS : Imbalanced nutrition less than the body requirement related to the Anorexia, nausea and dietary restriction and altered oral mucus membrane
SUBJECTIVE DATA OBJECTIVE DATA
Patient complaining of nausea and decrease in appetite
Patient intake is reduced as compared to requirement during lactation.
DESIRED GOAL/ OUTCOME To maintain adequate nutrition status by reducing nausea and increasing appetite
PLANNING IMPLEMENTATION RATIONALE
Assess intake and out put
Assess regularly laboratory values like bun, creatitine, s. electrolytes.
Provide patient food as per dietary requirement
Promoted intake of high biological value protein food e.g.;- egg, dairy products etc.
Encouraged high calorie low
Increased dietary intake
To maintain positive nitrogen balance
Required during lactation
Provide patient food as per dietary requirement
Promoted intake of high biological value protein food
protein low sodium diet
Administered anti emetics Tab rantac 50 mg T.D.S
Alteration of medication so that they be give afar meals
Explain the rationale of dietary restrictions
Provide clean surrounding
Assess intake and out put
Assess regularly laboratory values like bun, creatitine, s. electrolytes.
To reduce feeling of nausea
To reduce bad taste ue to medications
To reduce anxiety
To increase appetite
To check the increase in the nutritional status of the patient.
EVALUATION OF GOAL
Patient is maintaining normal nutritional status according to lactation
6. NURSING DIAGNOSIS : Impaired skin integrity related to edema as evidenced by redness itching over
the area of edema and also dryness
SUBJECTIVE DATA OBJECTIVE DATA Patient is saying she is having redness, dryness and itching over the area of edema on the leg
Patient is having redness, dryness over the area of edema on the leg
DESIRED GOAL/ OUTCOME
To maintain normal skin integrity.
PLANNING IMPLEMENTATION RATIONALE
change the position hourly during day
Applied emollient over the area of dryness
fluid intake up to 2 liters
Maintain hygiene
Avoid to wear tight clothing
Advised the patient to change the position hourly during day
Applied emollient over the area of dryness
Advised fluid intake up to 2 liters Advised patient not to lie on the
pressure points for longer periods.
Advised her to keep clean and dry and change clothing daily
Advised her not to ear tight clothing
Advised her to remove rings and bangles
To prevent pressure sores
To reduce dryness and itching
To reduce edema
To prevent development of ulcers
To maintain personal hygiene To maintain skin integrity
EVALUATION OF GOAL Patient redness is reduced and itching also reduced
7. NURSING DIAGNOSIS : Anxiety related to care of the baby and herself after delivery
SUBJECTIVE DATA OBJECTIVE DATA Patient is asking about care of the care of the baby and herself
Patient looks anxious
DESIRED GOAL/ OUTCOME
To reduce anxiety of the patient.
PLANNING IMPLEMENTATION RATIONALE
Explain eye and cord care
Explain maintaining personal hygiene of herself and the baby
Explain about the breast care and keeping the breast clean dry
Explain about diet Explain about
contraceptives.
Advised mother to keep the baby close to her
Explained mother about eye and cord care
Explained mother about maintaining personal hygiene of herself and the baby
Explained about the breast care and keeping the breast clean dry
Explained about diet
Explained about contraceptives.
To increase mother and child relation
To reduce infection of baby
To reduce anxiety
EVALUATION OF GOAL Patient looks less anxious and carrying out of the baby effectively.
8. NURSING DIAGNOSIS : Altered temperature due to disease condition
SUBJECTIVE DATA OBJECTIVE DATA
The patient is complaining of body pain Patient is warm to touch. Temp:- 101.6 F
DESIRED GOAL/ OUTCOME
Patient’s temperature will be reduced.
PLANNING IMPLEMENTATION RATIONALE
checked the body
temperature Given injection
encouraged patient to have plenty of fluids
provided hydration therapy to patient.
sent urine and blood culture to lab
checked the body temperature
Given injection paracetamol 1amp i/v stat.
encouraged patient to have plenty of fluids
provided hydration therapy to patient.
sent urine and blood culture to lab
reassessed the temperature after one hour of giving .
To gain mothers cooperation
to have baseline data. to treat fever as paracetamol is
antipyretic.
to prevent dehydration
to find out the cause of fever to check the effectiveness of
treatment given.
EVALUATION OF GOAL Patient’s temperature was reduced when assessed again .Temp: 99 F
DRUG STUDY
S.N
O
NAME OF
THE DRUG
PHARMACOLOGICAL
NAME
ACTION Dosage SIDE EFFECTS NURSING
RESPONSIBILITIES
1.
2.
Magneon/ magnesium
sulphate
Cervix gell
magnesium
sulphate
Prostaglandin E2
Increases osmotic pressure, draws fluid into colon, neutralizes HCl. Stimulates uterine contractions, causing
Loading dose: 4 gm IV over 3–5 min
followed by 10
gm deep IM (5 gm in each buttock)Maintenance
dose:
5 gm IM 4 hourly in
alternate buttock
500 micro gm.
Intracevically.
CNS: Muscle weakness, flushing, sweating, confusion, sedation, depressed reflexes, flaccid paralysis, hypothermia CV: Hypotension, heart block, circulatory collapse, vasodilation GI: Nausea, vomiting, anorexia, cramps, diarrhea HEMA: Prolonged bleeding time META: Electrolyte, fluid imbalances RESP: Respiratory depression/paralysis CNS: Headache, dizziness, chills, fever, flushing CV: Hypotension, dysrhythmias, DIC
Assess: Eclampsia: seizure precautions, B/P, ECG (magnesium sulfate); magnesium toxicity: thirst, confusion, decrease in reflexes; I&O ratio; check for decrease in urinary output Evaluate: • Therapeutic response: decreased constipation; absence of seizures (eclampsia), normal serum calcium levels Teach patient/family: • That chilling improves taste of magnesium citrate • To shake suspension well • Cervical ripening: dilation, effacement of cervix and uterine contraction, fetal heart tones, check
3.
Tab amlog
amLODIPine
abortion; acts within 30 hr for complete abortion Inhibits calcium ion influx across cell membrane during cardiac depolarization; produces
5 md o.d.
EENT: Blurred vision SYST: Anaphylactoid syndrome of pregnancy FETAL: Bradycardia (i.e., deceleration) GI: Nausea, vomiting, diarrhea GU: Vaginitis, vaginal pain, vulvitis, vaginismus INTEG: Rash, skin color changes MS: Leg cramps, joint swelling, weakness GEL: Uterine contractile abnormality, GI side effects, back pain, fever INSERT: Uterine hyperstimulation, fever, nausea, vomiting, diarrhea, abdominal Pain CNS: Headache, fatigue, dizziness, asthenia, anxiety, depression, insomnia, paresthesia, somnolence CV: Peripheral edema, bradycardia, hypotension, palpitations, syncope, chest painGI: Nausea, vomiting, diarrhea, gastric
for contractions over 1 min • For fever that occurs 1/2 hr after suppository insertion (abortion) • Respiratory rate, rhythm, depth; notify prescriber of abnormalities, pulse, B/P, temperature Vaginal discharge: check for itching, irritation; indicates vaginal infection Evaluate: • Therapeutic response: expulsion of fetus • To avoid hazardous activities until stabilized on product, dizziness is no longer a problemTo avoid OTC products unless directed by prescriber • To notify prescriber of irregular heartbeat; shortness of breath; swelling of feet, face, hands; severe dizziness; constipation; nausea; hypotension; if chest pain does not improve, use nitroglycerin when
4.
Cap.
Amclox
Ampicillin +
cloxacillin
relaxation of coronary vascular smooth muscle, peripheral vascular smooth muscle; dilates coronary vascular arteries; increasesmyocardial O2 delivery in patients with vasospastic angina Interferes with cell wall replication of susceptible organisms; the cell wall, rendered
500mg q.i.d
upset, constipation, flatulence, anorexia, gingival hyperplasia, dyspepsia GU: Nocturia, polyuria, sexual difficulties INTEG: Rash, pruritus, urticaria, alopecia OTHER: Flushing, muscle cramps, cough, weight gain, tinnitus, epistaxis CNS: Lethargy, hallucinations, anxiety, depression, twitching, coma, seizures GI: Nausea, vomiting, diarrhea, pseudomembranous colitis, stomatitis GU: Oliguria, proteinuria,
angina is severe • To use correct technique when monitoring pulse; to contact prescriber if pulse ,50 bpm • To avoid large amounts of grapefruit juice, alcohol • To change positions slowly to prevent orthostatic hypotension • To continue with good oral hygiene to prevent gingival disease • To use sunscreen, protective clothing to prevent photosensitivity • To notify all health care providers of use of this product Assess: • Infection: characteristics of wound, sputum, WBC; baseline, periodically; C&S before product therapy, product may be taken as soon as culture is taken Nephrotoxicity: I&O ratio;
5.
Tab. Brufen
ibuprofen
osmotically unstableswells, bursts from osmotic pressure; lysis mediated by cell wall autolysins Acts directly on cough center in medulla to suppress
400 mg B.D.
hematuria, vaginitis, moniliasis, glomerulonephritis HEMA: Anemia, increased bleeding time, bone marrow depression, granulocytopenia, leukopenia, eosinophilia, hemolysis INTEG: Rash, urticaria, erythema multiforme MISC: Anaphylaxis, serum sickness, Stevens-Johnson syndrome, toxic epidermal necrolysis CNS: Drowsiness, dizziness, light-headedness, confusion, headache, sedation, euphoria, dysphoria,
report hematuria, oliguria; renal studies: urinalysis, protein, blood, BUN, creatinine • Hepatic studies: AST, ALT • Blood studies: WBC, RBC, Hgb, Hct, bleeding time • Bowel pattern before, during treatment • Respiratory status: rate, character, wheezing, tightness in chest Anaphylaxis: rash, itching, dyspnea, facial swelling; stop product, notify prescriber,have emergency equipment available • To take oral ampicillin on empty stomach with full glass of water • That product must be taken in equal intervals around the clock to maintain blood levels Assess: • Pain: intensity, type, location, other characteristics before, 1 hr after giving
6
Tab rantac
Ranitidine
cough; binds to opiate receptors in CNS to reduce pain Inhibits histamine at H2-receptor site in parietal cells, which inhibits gastric acid secretion
50 mg B.D.
weakness, hallucinations, disorientation, mood changes, dependence, seizures CV: Palpitations, tachycardia, bradycardia, change in B/P, circulatory depression, syncope, cardiac arrest (children) EENT: Tinnitus, blurred vision, miosis, diplopia GI: Nausea, vomiting, anorexia, constipation, cramps, dry mouth, ulcers GU: Increased urinary output, dysuria, urinary retention INTEG: Rash, urticaria, flushing, pruritus RESP: Respiratory depression; pulmonary CNS: Headache, sleeplessness, dizziness, confusion, agitation, depression, hallucination (geriatric patients)CV: Tachycardia, bradycardia, PVCs EENT: Blurred vision, increased ocular
product; titrate upward by 25% until pain reduced by half; need for pain medication, physical dependence; opioid is more effective before pain is severe • CNS changes: dizziness, drowsiness, hallucinations, euphoria, LOC, pupil reaction • B/P, pulse, respirations before, periodically; if respirations ,10/min, dose may need to be reduced, oversedation may occur • Bowel status: constipation; Assess: • GI complaints: nausea, vomiting, diarrhea, cramps, abdominal discomfort, jaundice; report immediately • I&O ratio, BUN, creatinine, LFTs, serum, stool guaiac before, periodically
7.
Ferrous
sulphate
Ferrous
sulphate
Replaces iron stores needed for red blood cell development as well asenergy and O2
pressure GI: Constipation, abdominal pain, diarrhea, nausea, vomiting, hepatotoxicity GU: Impotence, acute interstitial nephritis (rare) INTEG: Urticaria, rash, fever RESP: Pneumonia SYST: Anaphylaxis (rare) GI: Nausea, constipation, epigastric pain, black and red tarry stools, vomiting, diarrhea INTEG: Temporarily discolored tooth enamel and eyes SYST: Hypersensitivity reactions (Ferrlecit)
during therapy Evaluate: • Therapeutic response: decreased abdominal pain, heartburn Teach patient/family: • To avoid driving, other hazardous activities until stabilized on product • That product must be continued for prescribed time to be effective • To notify prescriber if pregnancy planned, suspected; to avoid breastfeeding • Not to take maximum OTC daily dose for .2 wk • To take once daily dose before bedtime Assess: • Blood studies: Hct, Hgb, reticulocytes, bilirubin before treatment, at least monthly; iron studies (Iron, TIBC, ferritin). • Elimination: if constipation occurs, increase
transport and use; sulfate, 20%; iron, 30%; ferrous sulfate exsiccated
water, bulk, activity • Nutrition: amount of iron in diet (meat, dark green leafy vegetables, dried beans, dried fruits, eggs) Teach patient/family: • That iron will turn stools black or dark green • Accidental exposure: to keep out of reach of children, pets; iron poisoning may occur if increased beyond recommended level • To avoid reclining position for 15-30 min after taking product to avoid esophageal corrosion